James D. Brandt, a renown glaucoma specialist and professor of ophthalmology and vision science, received the humanitarian award from American Glaucoma Society earlier this month in New York City. The award recognizes his longstanding commitment and efforts to preserve vision and to improve the quality of life for those in need.
Brandt is director of the Glaucoma Service and vice chair for International Programs & New Technologies at the eye center. He has had a career-long emphasis on infantile and pediatric glaucoma.
For the last decade Brandt has traveled on some 20 programs around the world to treat children with glaucoma through a partnership he developed with Orbis International, a non-profit dedicated to saving sight worldwide.
Orbis’ focus on parallel training in pediatric anesthesia and perioperative care aims to address crucial gaps in care in resource-constrained countries, conditions that frequently prevent infants and young children from getting timely and appropriate surgical care.
UC Davis and Orbis are strategic partners, focusing on pediatric anesthesia training and simulation so that surgeons trained in pediatric glaucoma procedures will have local capacity to safely treat the most vulnerable patients.
Brandt also has served as principal investigator of numerous clinical trials, including the Ocular Hypertension Treatment Study and is collaborating with researchers in the fields of nanotechnology, micro-fabrication and biomedical engineering to develop new methods to measure outflow reistance in the living human eye.
Brandt received an undergraduate degree from Yale University and a medical degree from Harvard Medical School. He completed a two year-postdoctoral research fellowship in glaucoma-related pharmacology and cell biology at the Schepens Eye Research institute in Bosten He completed a residency at USC/LA County/Doheny Eye Institute and a glaucoma fellowship at Wills Eye Hospital in Philadelphia. He joined the UC Davis faculty in 1989.